You are here

Advisory Committee on Vaccines (ACV)

Related information

10 May 2022

Role of the ACV

The ACV provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) on issues relating to the safety, quality and efficacy of vaccines supplied in Australia including issues relating to pre-market assessment, post-market monitoring and safe use in national immunisation programs.

The Committee is established under Regulation 39F of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.

The ACV was established in January 2017, following consolidation of previous functions of the Advisory Committee on the Safety of Vaccines (ACSOV) and the pre-market functions for vaccines of the Advisory Committee on Prescription Medicines (ACPM).

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.



Professor Allen Cheng is an infectious diseases physician. His current appointments are as Director, Infection Prevention and Healthcare Epidemiology at Alfred Health, and Professor in the Department of Epidemiology and Preventative Medicine at Monash University. Professor Cheng has diverse clinical experience in metropolitan and regional hospitals in Australia and internationally, and research interests in clinical infectious diseases, tropical medicine and influenza and COVID epidemiology. His PhD thesis was on the bacterial disease melioidosis. Professor Cheng is the Vice-President of the Australasian Society for Infectious Diseases. He has published over 350 peer-reviewed scientific publications. He was previously co-chair of the Australian Technical Advisory Group on Immunisation (ATAGI) from 2018-21. Professor Cheng provides expertise in the field of infectious diseases in adults and children.


Professor Jim Buttery is an infectious disease clinician at the Royal Children's Hospital in Melbourne. Professor Buttery serves as the Head of Epidemiology and Surveillance for SAEFVIC and the inaugural Chair in Child Health Informatics at the University of Melbourne. He is currently serving on the Victorian Immunisation Advisory Committee and is a member of the Scientific Committee of the Brighton Collaboration. Professor Buttery provides expertise in infectious diseases in children, epidemiology, vaccine program implementation, and paediatrics.

Dr Jeanine Bygott is a medical practitioner with a specialty in microbiology and experience in travel medicine clinics in Australia and Ireland. Currently a consultant medical microbiologist at Sullivan Nicolaides Pathology, a private pathology laboratory in Queensland, she provides advice to general practitioners on the administration of vaccines. She has completed a Master of Public Health and Tropical Medicine and a Diploma Course in Vaccinology at the Pasteur Institute in Paris. She is also a Fellow of the Royal Australasian College of Pathologists in medical microbiology and virology. Dr Bygott provides expertise in bacteriology, virology, and the provision of immunisation treatment by an individual.

Ms Madeline Hall is a Nurse Practitioner specialising in vaccine preventable diseases with a special interest in vaccine safety. She has extensive experience in vaccine preventable diseases and is involved in advanced health assessments and risk screening of adults with specific vaccination requirements, such as persons who have had a previous serious or unexpected adverse event following immunisation, immuno-compromised persons, and those at occupational risk. Ms Hall is a member of ATAGI and a member of the Adverse Events Following Immunisation - Clinical Assessment Network. Ms Hall provides expertise in the fields of provision of immunisation treatment by an individual and nursing.

Professor Kristine Macartney is the Director of the National Centre for Immunisation Research & Surveillance, a paediatric infectious diseases specialist at The Children's Hospital at Westmead, and Professor in the Discipline of Paediatrics and Child Health, University of Sydney. She is the senior technical editor of the Australian Immunisation Handbook and has research interests in viral vaccine preventable diseases, vaccine safety and policy-making. Professor Macartney served on the Advisory Committee on the Safety of Vaccines throughout its period of operation. Professor Macartney provides expertise in the fields of vaccinology, adverse events surveillance (including as senior lead of the AusVaxSafety Program), infectious diseases, virology, epidemiology and paediatrics. She is a member of the World Health Organisation Global Advisory Committee on Vaccine Safety.

Dr Ines Rio is a specialist general practitioner with several postgraduate medical qualifications relevant to the provision of clinical care and the optimisation of healthcare systems. Over the past two decades, Dr Rio has combined her clinical work as a general practitioner with medical advisory, health care system governance and reform and leadership roles. Dr Rio has extensive experience in Board and high-level committee work, including membership on the Victorian Human Research Ethics Committee, the Medical Board of Victoria and in advisory committees for the Federal and Victorian Health Departments. Her current substantial roles in health care system governance and reform include being Chair of the Board of North Western Melbourne PHN (and Chair of its Clinical Council) and roles in the Federal and Victorian Australian Medical Association. Dr Rio provides expertise in the fields of public health, vaccine program implementation and the provision of immunisation treatment by an individual.

Dr Vicky Sheppeard is a public health physician specialising in communicable disease control. As Director of the Communicable Diseases Branch, NSW she delivered new immunisation programs, responded to emerging infectious disease threats, and adopted innovative technologies. Dr Sheppeard has also served as the NSW representative on Communicable Disease Network Australia and deputy chair of the National Immunisation Committee. Dr Vicky Sheppeard provides expertise in the fields of communicable disease control in adults and children and vaccine program implementation.

Associate Professor Adrienne Torda is a physician specialising in infectious diseases. She is a senior staff specialist in the Department of Infectious Diseases at the Prince of Wales Hospital, Sydney and an Associate Professor in the Faculty of Medicine, UNSW Sydney. She has a PhD, a Graduate Diploma of Bioethics, is an Associate Fellow of the Australia and New Zealand Association of Health Professional Educators and is a Senior Fellow of the Higher Education Academy. Her research interests include translational research topics such as vaccine coverage in vulnerable populations and diabetic foot infections. She is involved in a number of medical education research projects, examining the impact of educational innovations in medicine. From 2004 to 2007 she was a member of the National Influenza Pandemic Committee. Associate Professor Torda provides expertise in infectious diseases in adults and children.

Professor Joseph Torresi is an infectious diseases physician, virologist and an international leader in hepatitis, travel medicine and vaccinations and multi-centre collaborative research. He has over 20 years of experience as a molecular virologist with expertise in vaccine research and clinical trials, hepatitis B and C virology, dengue, influenza and SARS CoV2 vaccine development. Professor Torresi is a current board member of the International Society of Travel Medicine (ISTM) Foundation, a member of the Healthscope National Medical Council and a Fellow of the International Society of Travel Medicine, the Faculty of Travel Medicine of the Royal College of Physicians and Surgeons of Glasgow. He currently heads the Hepatitis and Virology Vaccine Research laboratory in the Department of Microbiology and Immunology at the Peter Doherty Institute, the University of Melbourne. Professor Torresi provides expertise in immunology, virology and vaccine program implementation.

Ms Diane Walsh is the Deputy Chair of the Board of the Northern Territory Primary Health Network (PHN), is currently on the Advisory Group of the PHN Immunisation Support Program and the Australian Technical Advisory Group on Immunisation. She previously served as the chair of the Top End Division of General Practice Board of Management for over 10 years, and has been a member of the Northern Territory Medical Board, the management committee of Health Consumers of Rural and Remote Australia, and the National Medicines Policy Committee. Ms Walsh provided the consumer perspective on the statutory Therapeutic Goods Committee, including on medicine labelling. She has worked as a school teacher and operated a small business. Ms Walsh provides expertise in health issues from the consumer perspective.

2022 ACV meeting dates

Meeting no. Meeting dates
29 7 January 2022
30 14 January 2022
31 8 February 2022
32 22 March 2022
33 1 June 2022
34 3 August 2022
35 5 October 2022
36 30 November 2022

Contact details for the ACV

Vaccines enquiries Committee support enquiries
Postal Address Advisory Committee on Vaccines
Therapeutic Goods Administration
PO Box 100
Attn: Pharmacovigilance and Special Access Branch, MDP 122
Committee Support Unit
Therapeutic Goods Administration
PO Box 100
Attn: Scheduling & Committee Support Section, MDP 122